Olivier Boisteau
Fundador en Clean Cells SAS .
Origen de la red de primer grado Olivier Boisteau.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.
17
| Subsidiary | Miscellaneous Commercial Services | 17 |
Clean Cells SAS
 Clean Cells SAS Miscellaneous Commercial ServicesCommercial Services Clean Cells SAS provides biosafety testing and biological characterization services. It also provides cell banking and storage, virus banking and storage, viral clearance, and assay development. The company was founded by Olivier Boisteau, Frederic Henry and Marc Meichenin on July 31, 2000 and is headquartered in Bouffere, France.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Olivier Boisteau a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Cisbio Bioassays SAS
 Cisbio Bioassays SAS Medical SpecialtiesHealth Technology Cisbio Bioassays SAS develops immunoassays and other related pharmaceutical products. The firm specializes in anti-bodies, vitro diagnostics, and medication for various diseases such as cancer and neurodegenerative disorder. The company was founded in 1986 and is headquartered in Codolet, France. | Medical Specialties | Chief Executive Officer | |
| CEGEDIM | Packaged Software | Director/Board Member | |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Director/Board Member | |
neckermann.de GmbH
 neckermann.de GmbH Catalog/Specialty DistributionRetail Trade The neckermann.de GmbH is a mail-order and multi-channel direct marketer firm. Its product offerings include apparel and shoes, leisure products, electronic and household products as well as furniture and home textiles. Neckermann’s specialty business, “Happy Size,” offers a plus size women’s apparel. The company was founded in 1950 and is headquartered in Frankfurt, Germany. | Catalog/Specialty Distribution | Director/Board Member | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member | |
| BLUEBIRD BIO, INC. | Biotechnology | Founder | |
Sofimac Innovation SAS
 Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Private Equity Investor | |
| Université de Montpellier | College/University | Doctorate Degree | |
World Health Organization
 World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Supranational | Corporate Officer/Principal | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
| Université Claude Bernard Lyon 1 | College/University | Undergraduate Degree | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
| Fondation Mérieux | Investment Trusts/Mutual Funds | Director/Board Member | |
AstraZeneca SAS
 AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Pharmaceuticals: Major | Chief Executive Officer | |
| Harvard Medical School | College/University | Graduate Degree | |
Egenix, Inc.
 Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Biotechnology | Director/Board Member | |
| University of Nantes | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Biotechnology | Chairman | |
bioMERIEUX Benelux SANV
 bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | Medical Specialties | Director/Board Member | |
| Société Française de Cardiologie | Corporate Officer/Principal | ||
| Fondation Centaure | Director/Board Member | ||
| Hopital Guillaume et René Laënnec | Corporate Officer/Principal | ||
| Société Française de Chirurgie Thoracique & Cardio-Vasculaire | Corporate Officer/Principal | ||
| Association Internationale pour la Transplantation Cardiaque | Corporate Officer/Principal | ||
| Société Européenne de Chirurgie Cardio-Vasculaire | Corporate Officer/Principal | ||
| Commission Nationale de Matériovigilance | Director/Board Member | ||
| Agence Française de Sécurité Sanitaire des Produits de Santé | Director/Board Member | ||
| Hopital Necker-Enfants Malades | Corporate Officer/Principal | ||
| French Cardiology Association | Corporate Officer/Principal | ||
| Fédération Françaises des Industries de Santé | Corporate Officer/Principal | ||
| Eratos Santé SARL | Corporate Officer/Principal | ||
| La Référence Formation des Industries de Santé | Director/Board Member | ||
| Medicines Patent Pool Foundation | Chairman | ||
| Kidney Disease Improving Global Outcomes | Corporate Officer/Principal | ||
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
Xenothera SAS
 Xenothera SAS BiotechnologyHealth Technology Xenothera SAS is a biotechnologies company. It creates therapeutic modes in numerous domains from immunomodulation to infectious diseases. The company was founded on June 30, 2014 and is headquartered in | Biotechnology | Chief Operating Officer | |
ASTRA France SA
 ASTRA France SA Miscellaneous Commercial ServicesCommercial Services Part of SES SA, ASTRA France SA is a French company that provides business and management consultancy services. The company is based in Paris, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
Fondation Coeur Et Recherche
 Fondation Coeur Et Recherche Miscellaneous Commercial ServicesCommercial Services Fondation Coeur Et Recherche operates a voluntary membership organization. The private company is based in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Institut De Formation Des Industries De Santé
 Institut De Formation Des Industries De Santé Miscellaneous Commercial ServicesCommercial Services Institut De Formation Des Industries De Santé is a private company based in Paris, France. The French company provides training services to the pharmaceutical and health sectors. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Société Française D Immunologie | Director/Board Member | ||
Global Antibiotic Research & Development Partnership
 Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Biotechnology | Director/Board Member | |
| Human Vaccine Project | Director/Board Member | ||
Inserm-Transfert SA
 Inserm-Transfert SA Miscellaneous Commercial ServicesCommercial Services Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman | |
| Université PSL | College/University | Director/Board Member | |
| DEEZER | Internet Software/Services | Human Resources Officer | |
BioMAdvanced Diagnostics SAS
 BioMAdvanced Diagnostics SAS Medical SpecialtiesHealth Technology BioMAdvanced Diagnostics SAS produces molecular diagnostic and biomarker tests related to the immune system. The company is based in Nantes, France. The French company was founded by Nicolas Bouler, Frédéric Pette, Sophie Brouard, Jean-Michel Bouler. Frédéric Pette has been the CEO since incorporation. | Medical Specialties | Founder |
Estadísticas
Internacional
| Francia | 37 |
| Estados Unidos | 6 |
| Suiza | 5 |
| Bélgica | 4 |
| Alemania | 3 |
Sectorial
| Health Technology | 13 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Technology Services | 4 |
| Miscellaneous | 3 |
Operativa
| Director/Board Member | 50 |
| Corporate Officer/Principal | 32 |
| Founder | 13 |
| Doctorate Degree | 10 |
| Chief Executive Officer | 10 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Olivier Boisteau
- Conexiones Empresas
